-
New Treatments Give Hope to Patients With One of the Deadliest Cancers
Dr. Benjamin Weinberg is interviewed along with other GI Oncologists sharing discussing research innovations in Pancreatic Cancers.
Category: News
-
John Marshall Unscripted: The Economics of Cancer Care and Inflation Reduction Act Ripple Effect
Dr. Marshall delves into the complex economics of cancer care in early 2025.
Category: News
-
https://www.docwirenews.com/post/checkmate-9dw-8hw-nest-and-bot-bal
Dr. Benjamin Weinberg provided his perspective on the CheckMate 9DW expanded analyses in liver cancer, as well as multiple studies in colorectal cancer, including CheckMate 8HW and NEST
Category: News
-
Ruesch Think Tank: Early Onset Cancers
Results of the Ruesch Center’s Early Onset GI Cancer Think Tank published in JNCI.
Category: News
-
Surgeon General’s alcohol warning: cancer
Dr. Benjamin Weinberg joins the Situation Room on CNN to discuss the Surgeon General’s Warming on the Link between Alcoholo and Cancer.
Category: News
-
Niche-3, CABINET, and Other GI Oncology Updates From ESMO 2024
Dr. Benjamin Weinberg shares updates from the recent ESMO meeting
Category: News
-
https://www.onclive.com/view/uncovering-the-power-of-introspection-to-drive-personalized-cancer-care
A series of events took John L. Marshall, MD, down his path of becoming a gastrointestinal oncology leader, with a drive that has also solidified him on the patient journey and enhancing their quality of care.
Category: News
-
Zolbetuximab’s Impact on Gastric/GEJ Adenocarcinoma
John Marshall, MD, discussed zolbetuximab, which the FDA recently approved for patients with CLDN18.2–positive locally advanced unresectable or metastatic HER2-negative gastric or GEJ adenocarcinoma.
Category: News
-
Celebrating 15th Anniversary Ruesch Center Honors Founder
Learn more about the 15th Annual Luminary Awards
Category: News
-
ctDNA Generates Momentum in Adjuvant Stage II/III Colon Cancer Setting
John L. Marshall, MD, details updates with ctDNA in colorectal cancer, and how precision medicine with ctDNA could change the way patients are treated.
Category: News